0001209191-17-026471.txt : 20170410 0001209191-17-026471.hdr.sgml : 20170410 20170410214303 ACCESSION NUMBER: 0001209191-17-026471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170406 FILED AS OF DATE: 20170410 DATE AS OF CHANGE: 20170410 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Pulse Biosciences, Inc. CENTRAL INDEX KEY: 0001625101 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 465696597 STATE OF INCORPORATION: NV FISCAL YEAR END: 1217 BUSINESS ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 BUSINESS PHONE: 650-697-3939 MAIL ADDRESS: STREET 1: 849 MITTEN ROAD STREET 2: SUITE 104 CITY: BURLINGAME STATE: CA ZIP: 94010 FORMER COMPANY: FORMER CONFORMED NAME: Electroblate, Inc. DATE OF NAME CHANGE: 20141113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DUGGAN ROBERT W CENTRAL INDEX KEY: 0001055919 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37744 FILM NUMBER: 17754790 MAIL ADDRESS: STREET 1: 611 SOUTH FORT HARRISON AVE STREET 2: SUITE 306 CITY: CLEARWATER STATE: FL ZIP: 33756 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-06 0 0001625101 Pulse Biosciences, Inc. PLSE 0001055919 DUGGAN ROBERT W 611 S. FORT HARRISON AVE., SUITE 306 CLEARWATER FL 33756 0 0 1 0 Common Stock 2017-04-06 4 P 0 21200 18.54 A 2408686 D Common Stock 2017-04-06 4 P 0 44200 19.703 A 2452886 D Common Stock 2017-04-07 4 P 0 94100 19.594 A 2546986 D Common Stock 2017-04-10 4 P 0 9200 20.375 A 2556186 D Common Stock 2017-04-10 4 P 0 22764 21.397 A 2578950 D This is the weighted average purchase price of the shares, which ranged from $18.122 to $18.79 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Includes 9,000 shares purchased by the Reporting Person that were inadvertently omitted from previous reports. This is the weighted average purchase price of the shares, which ranged from $19.125 to $19.976 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $19.079 to $20.00 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $20.05 to $20.50 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. This is the weighted average purchase price of the shares, which ranged from $21.13 to $21.616 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this Form 4. Brian Dow, as Attorney-in-Fact for Robert W. Duggan 2017-04-10